• Live
    • Audio Only
  • google plus
  • facebook
  • twitter
News > Peru

Peru To Acquire 30 Million Vaccines Against COVID-19

  • Martin Vizcarra at a press conference, Lima, Peru, August 21, 2020.

    Martin Vizcarra at a press conference, Lima, Peru, August 21, 2020. | Photo: Twitter/ @VargasJoeJohn1

Published 21 August 2020

The Health Ministry is speeding up the acquisition of medicines as the number of cases is still growing exponentially.

Peru’s President Martin Vizcarra Thursday announced the beginning of negotiations to get 30 million doses of COVID-19 vaccines from China, the United Kingdom, and the United States.


Peru: Doctors to Go on Strike for Better Working Conditions

"We are in discussions with five laboratories for the purchase of those doses and by the first half of 2021 we will have covered 90 percent of the population,” he said.

"At the end of August, we will conduct clinical trials for the Oxford University's COVID-19 vaccine and six thousand volunteers will take part in the research,” he added.

The President mentioned that it normally takes six months to acquire the batches once the medicine is ready. However, the Health Ministry will speed up the process as the number of cases and deaths is growing exponentially in the country.

By the end of August, the negotiations for the purchase of Oxford's vaccine will be completed. Next month, a deal will be closed with Johnson & Johnson Co. to receive its drugs.

Vizcarra mentioned that Peru is also coordinating with England to buy the Imperial College vaccine. With these three vaccines, from 60 to 70 percent of the population would be covered, which implies 20 million doses.

To complete the 30 million shots, Peru will depend on both China’s Sinovac and Sinopharm vaccines, which are is expected to be delivered in the country in early 2021.

As of Friday morning, Peru had reported 567,059 COVID-19 cases and 27,034 deaths.

Indigenous People in Peru are at risk of COVID-19.

Publicado por teleSUR English en  Martes, 14 de julio de 2020
Post with no comments.